Growth hormone axis

MGF and PEG-MGF explained: muscle, recovery and anti aging claims checked against lab and animal data, plus FDA compounding and WADA status.

CJC-1295 with DAC raised growth hormone for days in small 2006 studies. A trial was halted after a death, and FDA advisers voted against it.

Ipamorelin is an unapproved growth hormone peptide. Its one published sizable human trial failed, and FDA lists it as a significant safety risk.

Sermorelin was FDA approved as Geref for growth hormone deficiency in children, then discontinued. What studies in children and older adults show.

Tesamorelin (Egrifta) is FDA approved to cut excess belly fat in adults with HIV and lipodystrophy. What trials show on fat, liver, memory and risks.

Hexarelin explained: what small human studies found on growth hormone, muscle, fat, sleep and the heart, plus its risks and banned status.

CJC-1295 without DAC (Mod GRF 1-29) is an unapproved growth hormone peptide. FDA found no human, animal or safety studies of this form.